Minimally Invasive Surgery Plus Recombinant Tissue-type Plasminogen Activator for Intracerebral Hemorrhage Evacuation Decreases Perihematomal Edema
Author(s) -
W. Andrew Mould,
J. Ricardo Carhuapoma,
John Muschelli,
Karen Lane,
Timothy C. Morgan,
Nichol McBee,
Amanda J. Bistran-Hall,
Natalie Ullman,
Paul Vespa,
Neil A. Martin,
Issam A. Awad,
Mario Zuccarello,
Daniel F. Hanley
Publication year - 2013
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.000411
Subject(s) - medicine , intracerebral hemorrhage , plasminogen activator , surgery , edema , tissue plasminogen activator , recombinant tissue plasminogen activator , stroke (engine) , t plasminogen activator , recombinant dna , vascular disease , ischemic stroke , subarachnoid hemorrhage , ischemia , mechanical engineering , biochemistry , chemistry , modified rankin scale , engineering , gene
Perihematomal edema (PHE) can worsen outcomes after intracerebral hemorrhage (ICH). Reports suggest that blood degradation products lead to PHE. We hypothesized that hematoma evacuation will reduce PHE volume and that treatment with recombinant tissue-type plasminogen activator (rt-PA) will not exacerbate it.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom